Skip to content
2000
Volume 10, Issue 1
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

Despite improvements in neonatal care, survivors of preterm birth are still at a significantly increased risk of developing life-long neurological difficulties including cerebral palsy and cognitive difficulties. Cranial ultrasound is routinely used in neonatal practice, but has a low sensitivity for identifying later neurodevelopmental difficulties. Magnetic Resonance Imaging (MRI) can be used to identify intracranial abnormalities with greater diagnostic accuracy in preterm infants, and theoretically might improve the planning and targeting of long-term neurodevelopmental care; reducing parental stress and unplanned healthcare utilisation; and ultimately may improve healthcare cost effectiveness. Furthermore, MR imaging offers the advantage of allowing the quantitative assessment of the integrity, growth and function of intracranial structures, thereby providing the means to develop sensitive biomarkers which may be predictive of later neurological impairment. However further work is needed to define the accuracy and value of diagnosis by MR and the techniques’s precise role in care pathways for preterm infants.

Loading

Article metrics loading...

/content/journals/cpr/10.2174/157339631001140408120821
2014-02-01
2025-05-25
Loading full text...

Full text loading...

/content/journals/cpr/10.2174/157339631001140408120821
Loading

  • Article Type:
    Research Article
Keyword(s): biomarker; brain; MRI; neurodevelopmental outcome; Preterm infant
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test